Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A00855 | 34945573 | Foods | The Regulatory Effects of Citrus Peel Powder on Liver Metabolites and Gut Flora in Mice with Non-Alcoholic Fatty Liver Disease (NAFLD). | 2021 | Details |
| A00856 | 34945051 | J Clin Med | Low Screening Rates Despite a High Prevalence of Significant Liver Fibrosis in People with Diabetes from Primary and Secondary Care. | 2021 | Details |
| A00857 | 34945016 | J Clin Med | Non-Alcoholic Fatty Liver Disease (NAFLD) and Bariatric/Metabolic Surgery as Its Treatment Option: A Review. | 2021 | Details |
| A00858 | 34944736 | Biomedicines | Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00859 | 34944732 | Biomedicines | Therapeutic Opportunities of IL-22 in Non-Alcoholic Fatty Liver Disease: From Molecular Mechanisms to Clinical Applications. | 2021 | Details |
| A00860 | 34944730 | Biomedicines | Metabolic Fatty Liver Disease in Children: A Growing Public Health Problem. | 2021 | Details |
| A00861 | 34944728 | Biomedicines | Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism. | 2021 | Details |
| A00862 | 34944726 | Biomedicines | NASH and Systemic Complications: From Basic to Clinical Research. | 2021 | Details |
| A00863 | 34944709 | Biomedicines | Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment. | 2021 | Details |
| A00864 | 34944706 | Biomedicines | The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis-Systematic Review and Meta-Analysis. | 2021 | Details |
| A00865 | 34944682 | Biomedicines | Metabolic Associated Fatty Liver Disease in Children-From Atomistic to Holistic. | 2021 | Details |
| A00866 | 34944668 | Biomedicines | The Role of Physical Activity in Nonalcoholic and Metabolic Dysfunction Associated Fatty Liver Disease. | 2021 | Details |
| A00867 | 34944593 | Biomedicines | Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00868 | 34944567 | Biomedicines | Ability of a Combined FIB4/miRNA181a Score to Predict Significant Liver Fibrosis in NAFLD Patients. | 2021 | Details |
| A00869 | 34944525 | Biomolecules | A System-Level Mechanism of Anmyungambi Decoction for Obesity: A Network Pharmacological Approach. | 2021 | Details |
| A00870 | 34944452 | Biomolecules | Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease. | 2021 | Details |
| A00871 | 34944021 | Cells | IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism. | 2021 | Details |
| A00872 | 34943946 | Cells | Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese Ay Mice. | 2021 | Details |
| A00873 | 34943942 | Cells | MXD3 Promotes Obesity and the Androgen Receptor Signaling Pathway in Gender-Disparity Hepatocarcinogenesis. | 2021 | Details |
| A00874 | 34943908 | Cells | Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00875 | 34943814 | Cells | Exercise-Induced Irisin Decreases Inflammation and Improves NAFLD by Competitive Binding with MD2. | 2021 | Details |
| A00876 | 34943809 | Cells | Recent Advances in Adipose Tissue Dysfunction and Its Role in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00877 | 34943553 | Diagnostics (Basel) | Pemafibrate Ameliorates Liver Dysfunction and Fatty Liver in Patients with Non-Alcoholic Fatty Liver Disease with Hypertriglyceridemia: A Retrospective Study with the Outcome after a Mid-Term Follow-Up. | 2021 | Details |
| A00878 | 34943469 | Diagnostics (Basel) | Fatty Liver Index for Predicting Nonalcoholic Fatty Liver Disease in an Asymptomatic Korean Population. | 2021 | Details |
| A00879 | 34943221 | Biology (Basel) | Beta vulgaris L. (Beetroot) Methanolic Extract Prevents Hepatic Steatosis and Liver Damage in T2DM Rats by Hypoglycemic, Insulin-Sensitizing, Antioxidant Effects, and Upregulation of PPARα. | 2021 | Details |
| A00880 | 34943134 | Antioxidants (Basel) | Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. | 2021 | Details |
| A00881 | 34943104 | Antioxidants (Basel) | The Synbiotic Combination of Akkermansia muciniphila and Quercetin Ameliorates Early Obesity and NAFLD through Gut Microbiota Reshaping and Bile Acid Metabolism Modulation. | 2021 | Details |
| A00882 | 34943103 | Antioxidants (Basel) | Association of Serum Bilirubin and Functional Variants of Heme Oxygenase 1 and Bilirubin UDP-Glucuronosyl Transferase Genes in Czech Adult Patients with Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00883 | 34942625 | Dig Dis | Clinical profiles of Asians with NAFLD: A systematic review and meta-analysis. | 2021 | Details |
| A00884 | 34942286 | J Hepatol | Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. | 2021 | Details |
| A00885 | 34941988 | J Gastrointestin Liver Dis | The Role of Psychotherapy in the Treatment of Patients with Non- alcoholic Fatty Liver Disease and Obstructive Sleep Apnea. | 2021 | Details |
| A00886 | 34941156 | Medicine (Baltimore) | Effectiveness and safety of Shugan Jianpi (SGJP) formula in the treatment of nonalcoholic steatohepatitis (NASH): A protocol for systematic review and meta-analysis of randomized controlled trials. | 2021 | Details |
| A00887 | 34941049 | Medicine (Baltimore) | Acupuncture combined with Chinese herbal medicine on non-alcoholic fatty liver disease: A protocol for systematic review and meta-analysis. | 2021 | Details |
| A00888 | 34940698 | Mar Drugs | Soluble Polysaccharide Derived from Laminaria japonica Attenuates Obesity-Related Nonalcoholic Fatty Liver Disease Associated with Gut Microbiota Regulation. | 2021 | Details |
| A00889 | 34939204 | Hepatology | Angiotensin-converting enzyme inhibitors prevent liver-related events in nonalcoholic fatty liver disease. | 2021 | Details |
| A00890 | 34939092 | Eur J Prev Cardiol | Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis. | 2022 | Details |
| A00891 | 34939051 | J Mass Spectrom Adv Clin Lab | A pilot study optimizing metabolomic and lipidomic acquisition in serum for biomarker discovery in nonalcoholic fatty liver disease. | 2021 | Details |
| A00892 | 34938809 | Biomed Res Int | WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A00893 | 34938631 | Cureus | Glycogenic Hepatopathy as the Etiology of Abnormal Liver Chemistries in an Uncontrolled Type I Diabetic Patient. | 2021 | Details |
| A00894 | 34938271 | Front Endocrinol (Lausanne) | Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A00895 | 34938205 | Front Physiol | Ectodysplasin A/Ectodysplasin A Receptor System and Their Roles in Multiple Diseases. | 2021 | Details |
| A00896 | 34938193 | Front Pharmacol | Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model. | 2021 | Details |
| A00897 | 34938090 | Diabetes Metab Syndr Obes | The Predictive Ability of Hepatic Steatosis Index for Gestational Diabetes Mellitus and Large for Gestational Age Infant Compared with Other Noninvasive Indices Among Chinese Pregnancies: A Preliminary Double-center Cohort Study. | 2021 | Details |
| A00898 | 34935645 | JCI Insight | Maternal Western diet exposure increases periportal fibrosis beginning in utero in nonhuman primate offspring. | 2021 | Details |
| A00900 | 34935140 | Br J Pharmacol | Mineralocorticoid receptors in non-alcoholic fatty liver disease. | 2022 | Details |
| A00901 | 34934197 | Acta Pharmacol Sin | GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis. | 2021 | Details |
| A00902 | 34934162 | Sci Rep | Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes. | 2021 | Details |
| A00903 | 34933963 | Open Heart | Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis. | 2021 | Details |
| A00904 | 34933429 | Zhonghua Gan Zang Bing Za Zhi | [AGT rs5051 gene polymorphism increases the risk of coronary heart disease in patients with non-alcoholic fatty liver disease in the Han Chinese population]. | 2021 | Details |
| A00905 | 34933428 | Zhonghua Gan Zang Bing Za Zhi | [Studying the correlation between ferritin and non-alcoholic fatty liver disease]. | 2021 | Details |
| A00906 | 34933427 | Zhonghua Gan Zang Bing Za Zhi | [Abnormal expression of CD44 aggravates liver disease progression in patients with non-alcoholic fatty liver disease accompanied with hepatitis B virus replication]. | 2021 | Details |
| A00907 | 34933426 | Zhonghua Gan Zang Bing Za Zhi | [Quantitative analysis of non-alcoholic fatty liver disease based on MRI proton density fat fraction in the coastal region of Qingdao]. | 2021 | Details |
| A00908 | 34933425 | Zhonghua Gan Zang Bing Za Zhi | [Intestinal flora polymorphisms with different lesional stages in an animal model of MAFLD]. | 2021 | Details |
| A00909 | 34933319 | Ultrasonography | Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease. | 2021 | Details |
| A00910 | 34933288 | Phys Med Biol | Noninvasive estimation of local speed of sound by pulse-echo ultrasound in a rat model of nonalcoholic fatty liver. | 2022 | Details |
| A00912 | 34932603 | PLoS One | Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review. | 2021 | Details |
| A00913 | 34932136 | Diabetologia | Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver disease. | 2021 | Details |
| A00914 | 34931979 | Curr Mol Med | Endogenous liver protections against lipotoxicity and oxidative stress to avoid the progression of non-alcoholic fatty liver to more serious disease. | 2022 | Details |
| A00915 | 34931492 | Hepatol Commun | Alcohol Consumption and Cardiovascular Outcomes in Patients With Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study. | 2021 | Details |
| A00916 | 34931080 | Nat Metab | Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity. | 2021 | Details |
| A00917 | 34930143 | BMC Gastroenterol | Association of HSD17B13 rs72613567: TA allelic variant with liver disease: review and meta-analysis. | 2021 | Details |
| A00918 | 34929996 | Minerva Gastroenterol (Torino) | Evaluation of MACK-3 parameters, metabolic and fibrotic characteristics of non-alcoholic fatty liver disease patients with hypertension. | 2021 | Details |
| A00919 | 34929490 | EBioMedicine | Peripheral immune cells in NAFLD patients: A spyhole to disease progression. | 2021 | Details |
| A00920 | 34929391 | Clin Gastroenterol Hepatol | Prevalence of High and Moderate Risk Nonalcoholic Fatty Liver Disease Among Adults in the United States, 1999-2016. | 2021 | Details |
| A00921 | 34929318 | Gastroenterol Hepatol | Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease. | 2021 | Details |
| A00922 | 34928469 | Adv Ther | Changes in Platelet Counts and Thrombocytopenia Risk in Patients with Chronic Liver Disease with Different Etiologies Using Real-World Japanese Data. | 2021 | Details |
| A00923 | 34928415 | Eur Radiol | MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T. | 2021 | Details |
| A00924 | 34928287 | Food Funct | Identification of mitochondria-related hub genes in sarcopenia and functional regulation of MFG-E8 on ROS-mediated mitochondrial dysfunction and cell cycle arrest. | 2022 | Details |
| A00925 | 34927450 | J Am Heart Assoc | Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort. | 2021 | Details |
| A00926 | 34927282 | Drug Dev Res | Schisandrin B ameliorates non-alcoholic liver disease through anti-inflammation activation in diabetic mice. | 2021 | Details |
| A00927 | 34927277 | Aliment Pharmacol Ther | Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. | 2021 | Details |
| A00928 | 34927251 | Eur J Clin Invest | De novo lipogenesis in non-alcoholic fatty liver disease: Quantification with stable isotope tracers. | 2022 | Details |
| A00929 | 34927020 | iScience | Liver sphingomyelin synthase 1 deficiency causes steatosis, steatohepatitis, fibrosis, and tumorigenesis: An effect of glucosylceramide accumulation. | 2021 | Details |
| A00930 | 34926735 | Regen Ther | Characterization of adipose tissue-derived stromal cells of mice with nonalcoholic fatty liver disease and their use for liver repair. | 2021 | Details |
| A00931 | 34926533 | Front Med (Lausanne) | Sex-Specific Differences in the Association Between Race/Ethnicity and NAFLD Among US Population. | 2021 | Details |
| A00932 | 34925237 | Front Endocrinol (Lausanne) | Current and Potential Therapies Targeting Inflammation in NASH. | 2021 | Details |
| A00933 | 34925033 | Front Pharmacol | Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A00934 | 34924365 | J Obes Metab Syndr | Severe Obesity in Children and Adolescents: Metabolic Effects, Assessment, and Treatment. | 2021 | Details |
| A00935 | 34924319 | Dig Liver Dis | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00936 | 34924246 | Nutr Metab Cardiovasc Dis | Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO). | 2021 | Details |
| A00937 | 34923965 | BMC Gastroenterol | Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. | 2021 | Details |
| A00938 | 34923950 | Curr Mol Pharmacol | Potential Natural Compounds for the Prevention and Treatment of Nonalcoholic Fatty Liver Disease: A Review on Molecular Mechanisms. | 2021 | Details |
| A00939 | 34923473 | Wiad Lek | FEASIBILITY OF CYSTATIN C DETERMINATION FOR EARLY DIAGNOSIS OF KIDNEY DAMAGE IN PATIENTS WITH TYPE 2 DIABETES COMBINED WITH NONALCOHOLIC FATTY LIVER DISEASE AND OBESITY EXPOSED TO COVID-19 INFECTION IN THE PAST. | 2021 | Details |
| A00940 | 34923463 | Wiad Lek | INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A00941 | 34923459 | Wiad Lek | THE EFFECTIVENESS OF COMPLEX THERAPY WITH THE INCLUSION OF THE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE IN COMBINATION WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE. | 2021 | Details |
| A00942 | 34923456 | Wiad Lek | INTESTINAL LESIONS OCCURRING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AFTER SUFFERING THE COVID-19 INFECTION. | 2021 | Details |
| A00943 | 34923087 | J Ethnopharmacol | Highland barley Monascus purpureus Went extract ameliorates high-fat, high-fructose, high-cholesterol diet induced nonalcoholic fatty liver disease by regulating lipid metabolism in golden hamsters. | 2021 | Details |
| A00944 | 34922811 | J Diabetes Complications | DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. | 2021 | Details |
| A00945 | 34922644 | Lancet Diabetes Endocrinol | Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia. | 2021 | Details |
| A00946 | 34922604 | Trials | Omega-3 mechanism of action in inflammation and endoplasmic reticulum stress in mononuclear cells from overweight non-alcoholic fatty liver disease participants: study protocol for the "Brazilian Omega Study" (BROS)-a randomized controlled trial. | 2021 | Details |
| A00947 | 34922572 | Nutr Metab (Lond) | Alleviating the effect of quinoa and the underlying mechanism on hepatic steatosis in high-fat diet-fed rats. | 2021 | Details |
| A00948 | 34922062 | Clin Res Hepatol Gastroenterol | Awareness of chronic liver diseases, a comparison between diabetologists and general practitioners. | 2021 | Details |
| A00949 | 34922061 | Clin Res Hepatol Gastroenterol | Upregulated NLRP3 inflammasome activation is attenuated by anthocyanins in patients with nonalcoholic fatty liver disease: A case-control and an intervention study. | 2021 | Details |
| A00950 | 34921696 | Biofactors | High-fat-induced nonalcoholic fatty liver potentiates vulnerability to and the severity of viral hepatitis in a C3H/HeN mouse model. | 2021 | Details |
| A00951 | 34921208 | Sci Rep | Dual role of neutrophils in modulating liver injury and fibrosis during development and resolution of diet-induced murine steatohepatitis. | 2021 | Details |
| A00952 | 34921174 | Sci Rep | Elevated serum S14 levels are associated with more severe liver steatosis by ultrasonography. | 2021 | Details |
| A00955 | 34920070 | Int J Biol Macromol | MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila. | 2021 | Details |
| A00956 | 34919684 | J Nutr | A Specifically Tailored Multistrain Probiotic and Micronutrient Mixture Affects Nonalcoholic Fatty Liver Disease-Related Markers in Patients with Obesity after Mini Gastric Bypass Surgery. | 2022 | Details |
| A00957 | 34919585 | PLoS One | Characteristics of opioid prescribing to outpatients with chronic liver diseases: A call for action. | 2021 | Details |
| A00958 | 34919135 | JAMA Netw Open | Intermittent Fasting and Obesity-Related Health Outcomes: An Umbrella Review of Meta-analyses of Randomized Clinical Trials. | 2021 | Details |